February
Nordic Market Access Made Simple
Clear insight into payer pathways and decision-making across Denmark, Finland, Norway and Sweden
Join Nordic market access expert Katja Lundell for a practical guide to navigating payer pathways across the region. Gain clarity on how decisions are made, who holds influence and what strategies can speed patient access to innovative medicines.
March
Novel and Creative, Pricing and Reimbursement Strategies
Exploring flexible, evidence-based approaches to access and value
Join our expert Adam Lloyd to explore how creativity and collaboration can unlock smarter pricing and reimbursement outcomes. Learn how evolving market dynamics and evidence challenges are reshaping access strategies across therapy areas.
VPAG 2026
Expert insights on pricing, access and policy changes shaping the year ahead
Join our expert panel as they review the latest updates to the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) and what they mean for Life Sciences in 2026.